Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1093/ecco-jcc/jjaa150 http://scihub22266oqcxt.onion/10.1093/ecco-jcc/jjaa150 32722757!7454473!32722757     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32722757&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       J+Crohns+Colitis 2020 ; 14 (14 Suppl 3): S774-S779 Nephropedia Template TP {{tp|p=32722757|t=2020. Care of the Patient With IBD Requiring Hospitalisation During the COVID-19 Pandemic |pdf=|usr=}}{{32722757}} gab.com Text Care of the Patient With IBD Requiring Hospitalisation During the COVID-19 Pandemic JO: J Crohns Colitis http://www.kidney.de/pget.php?&tw=1&pmid=32722757 #FOAvip The management of IBD has been highly affected in the context of the COVID-19 pandemic, with restriction of hospitalisations and unprecedented redeployment of health care resources. Hospital admissions of IBD patients should be limited to reduce the risks of coronavirus transmission. However, delaying hospitalisation of IBD patients with severe or complicated disease may increase the risk of poor outcomes. Delaying surgery in some cases may increase the risk of disease progression, postoperative morbidity, and disease complications. IBD patients who are infected with SARS-CoV-2 may have a higher risk of poor outcomes than the general population, potentially related to concomitant medications, especially corticosteroids. There is no evidence today that IBD patients with COVID-19 have worse outcomes if they receive immunosuppressant medications including thiopurines, biologics, and novel small molecules. This article summarises recommendations by the international membership of IOIBD regarding hospitalisations of IBD patients, either for active or complicated IBD or for severe COVID-19, and for management of IBD patients according to SARS-CoV-2 infectious status. Twit Text FOAVip Care of the Patient With IBD Requiring Hospitalisation During the COVID-19 Pandemic ????J Crohns Colitis http://www.kidney.de/pget.php?&tw=1&pmid=32722757 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32722757 #FOAvip English Wikipedia <ref>{{Cite pmid|32722757}}</ref> Care of the Patient With IBD Requiring Hospitalisation During the COVID-19 Pandemic #MMPMID32722757 Allez M; Fleshner P; Gearry R; Lakatos PL; Rubin DT J Crohns Colitis 2020[Oct]; 14 (14 Suppl 3): S774-S779 PMID32722757show ga The management of IBD has been highly affected in the context of the COVID-19 pandemic, with restriction of hospitalisations and unprecedented redeployment of health care resources. Hospital admissions of IBD patients should be limited to reduce the risks of coronavirus transmission. However, delaying hospitalisation of IBD patients with severe or complicated disease may increase the risk of poor outcomes. Delaying surgery in some cases may increase the risk of disease progression, postoperative morbidity, and disease complications. IBD patients who are infected with SARS-CoV-2 may have a higher risk of poor outcomes than the general population, potentially related to concomitant medications, especially corticosteroids. There is no evidence today that IBD patients with COVID-19 have worse outcomes if they receive immunosuppressant medications including thiopurines, biologics, and novel small molecules. This article summarises recommendations by the international membership of IOIBD regarding hospitalisations of IBD patients, either for active or complicated IBD or for severe COVID-19, and for management of IBD patients according to SARS-CoV-2 infectious status. |*Betacoronavirus/isolation & purification[MESH] |*Hospitalization[MESH] |COVID-19[MESH] |COVID-19 Testing[MESH] |Clinical Laboratory Techniques[MESH] |Coronavirus Infections/complications/diagnosis/*therapy[MESH] |Humans[MESH] |Inflammatory Bowel Diseases/complications/*therapy[MESH] |Pandemics[MESH] |Pneumonia, Viral/complications/diagnosis/*therapy[MESH]Care of the Patient With IBD Requiring Hospitalisation During the COVI(epmc).pdf DeepDyve Pubget Overpricing